Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 161
Infectious Diseases Drugs 123
Genomics 100
Liver and Kidney Disorders Drugs 68
Immune Disorders Drugs 61
Pharmaceuticals 52
Drug Discovery 48
Cardiovascular Drugs 44
Biopharmaceuticals 42
Biotechnology 41
Leukemia Drugs 37
HIV/AIDS Drugs 37
Lymphoma Drugs 29
Allergy and Immunology 28
Clinical Trials 28
Musculoskeletal Disorders Drugs 27
Enzymes 26
Respiratory Drugs 25
Oncology 22
Pulmonary Medicine 20
Central Nervous System Drugs 20
Drug Delivery 19
Infusions and Injectables 17
Pharmaceutical Manufacturing 17
Gastrointestinal Drugs 13
Infectious Disease Testing 12
Vaccines 12
Endocrine and Metabolic Disorders Drugs 12
Healthcare Services 10
Diagnostics 10
Hematological Drugs 10
Sexual and Reproductive Health Drugs 10
Hematology 9
Antibiotics 9
Pharmaceutical Intermediates 8
Therapeutic Area 8
Optical Disorders Drugs 8
Breast Cancer Drugs 8
Stem Cells 8
Drugs by Therapeutic Area 6
Lung Cancer Drugs 6
Hepatology 5
Women's Health 5
Colon Cancer Drugs 5
Analgesics 5
Nanomedicine 5
Company Reports 4
Cervical Cancer Drugs 4
Anesthetic Drugs 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Liver Cancer Drugs 3
Generic Drugs 3
Bladder Cancer Drugs 3
Dental 3
Optical 3
Medical Devices 3
Needles and Syringes 3
Over the Counter (OTC) Drugs 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
E-Healthcare 2
Pharmacoeconomics 2
Prostate Cancer Drugs 2
Ovarian Cancer Drugs 2
Brain Cancer Drugs 2
In Vitro Diagnostics 2
Cancer Vaccines 2
Kidney Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Pediatrics 2
Gastroenterology 2
Cardiology 2
Urological Disorders Drugs 2
Animal Pharmaceuticals 1
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Proteomics 1
Cardiovascular Devices 1
Home Testing and Home Healthcare 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Blood Banking 1
Hospital Management 1
Surgical Procedures 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



284 reviews

1,018 Results (Page 36 of 51)
- Relevance
  Sort by

Cardiovascular Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

 Report
May 2025
118 Pages
Global

From

€4366EUR$4,750USD£3,721GBP

Infectious Disease Therapeutics Market - Global Forecast 2026-2032

 Report
January 2026
199 Pages
Global

From

€3259EUR$3,545USD£2,777GBP

€3621EUR$3,939USD£3,086GBP

Ebola Treatment Market - Global Forecast 2026-2032

 Report
January 2026
191 Pages
Global

From

€3259EUR$3,545USD£2,777GBP

€3621EUR$3,939USD£3,086GBP

Drugs for PrEP Market - Global Forecast 2026-2032

 Report
September 2026
180 Pages
Global

From

€3259EUR$3,545USD£2,777GBP

€3621EUR$3,939USD£3,086GBP

Filgotinib Tablets Market - Global Forecast 2026-2032

 Report
September 2026
185 Pages
Global

From

€3259EUR$3,545USD£2,777GBP

€3621EUR$3,939USD£3,086GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Oral JAK Inhibitors Market - Global Forecast 2026-2032

 Report
September 2026
194 Pages
Global

From

€3259EUR$3,545USD£2,777GBP

€3621EUR$3,939USD£3,086GBP

Pharmaceutical Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,518GBP

Blastomycosis Market - Global Forecast 2026-2032

 Report
January 2026
188 Pages
Global

From

€3259EUR$3,545USD£2,777GBP

€3621EUR$3,939USD£3,086GBP

PD-1 and PD-L1 Inhibitors - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

 Report
August 2026
160 Pages
Global

From

€4366EUR$4,750USD£3,721GBP

Letermovir Drugs Market - Global Forecast 2026-2032

 Report
September 2026
197 Pages
Global

From

€3259EUR$3,545USD£2,777GBP

€3621EUR$3,939USD£3,086GBP

Cytomegalovirus Treatment Market - Global Forecast 2026-2032

 Report
January 2026
191 Pages
Global

From

€3259EUR$3,545USD£2,777GBP

€3621EUR$3,939USD£3,086GBP

Global PDGFR Inhibitors Market, Drug Sales & Clinical Trials Insight 2026

 Report
October 2021
150 Pages
Global

From

€2206EUR$2,400USD£1,880GBP

Liposome Drug Delivery Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

 Report
November 2023
115 Pages
Global

From

€4137EUR$4,500USD£3,526GBP

Aspergillosis Treatment Drug Market - Global Forecast 2026-2032

 Report
September 2026
181 Pages
Global

From

€3259EUR$3,545USD£2,777GBP

€3621EUR$3,939USD£3,086GBP

Collagen Vascular Diseases Market - Global Forecast 2026-2032

 Report
January 2026
191 Pages
Global

From

€3259EUR$3,545USD£2,777GBP

€3621EUR$3,939USD£3,086GBP

Anti-Rheumatics Market - Global Forecast 2026-2032

 Report
January 2026
194 Pages
Global

From

€3259EUR$3,545USD£2,777GBP

€3621EUR$3,939USD£3,086GBP

A Review of the Best Selling Pharmaceutical Drugs in 2021: 2023 Research Report

 Report
February 2023
255 Pages
Global

From

€2298EUR$2,500USD£1,959GBP

Nucleic Acid-Based Drugs Market - Global Forecast 2026-2032

 Report
January 2026
183 Pages
Global

From

€3259EUR$3,545USD£2,777GBP

€3621EUR$3,939USD£3,086GBP

Global Markets for Treatments for Syndromes of Progressive Ataxia and Weakness Disorders

 Report
September 2023
180 Pages
Global

From

€4274EUR$4,650USD£3,643GBP

Autologous Stem Cell and Non-Stem Cell Based Therapies Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

 Report
April 2023
120 Pages
Global

From

€4366EUR$4,750USD£3,721GBP

1,018 Results (Page 36 of 51)
- 1
- 34
- 35
- 36
- 37
- 38

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.